Advertisement
Regular article|Articles in Press

Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy

  • Natalia Vilchinskaya
    Affiliations
    Institute of Biomedical Problems, Moscow, Russia
    Search for articles by this author
  • Wooi Fang Lim
    Affiliations
    Department of Paediatrics, University of Oxford Children's Hospital, John Radcliffe Hospital, Oxford, United Kingdom

    Institute of Developmental and Regenerative Medicine, Oxford, United Kingdom

    MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, United Kingdom
    Search for articles by this author
  • Svetlana Belova
    Affiliations
    Institute of Biomedical Problems, Moscow, Russia
    Search for articles by this author
  • Thomas C. Roberts
    Affiliations
    Department of Paediatrics, University of Oxford Children's Hospital, John Radcliffe Hospital, Oxford, United Kingdom

    Institute of Developmental and Regenerative Medicine, Oxford, United Kingdom

    MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, United Kingdom
    Search for articles by this author
  • Matthew J.A. Wood
    Affiliations
    Department of Paediatrics, University of Oxford Children's Hospital, John Radcliffe Hospital, Oxford, United Kingdom

    Institute of Developmental and Regenerative Medicine, Oxford, United Kingdom

    MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, United Kingdom
    Search for articles by this author
  • Yulia Lomonosova
    Correspondence
    Address correspondence to Yulia Lomonosova, Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom.
    Affiliations
    Department of Paediatrics, University of Oxford Children's Hospital, John Radcliffe Hospital, Oxford, United Kingdom

    Institute of Developmental and Regenerative Medicine, Oxford, United Kingdom

    MDUK Oxford Neuromuscular Centre, University of Oxford, Oxford, United Kingdom
    Search for articles by this author
      The principal mechanism underlying the reduced rate of protein synthesis in atrophied skeletal muscle is largely unknown. Eukaryotic elongation factor 2 kinase (eEF2k) impairs the ability of eukaryotic translation elongation factor 2 (eEF2) to bind to the ribosome via T56 phosphorylation. Perturbations in the eEF2k/eEF2 pathway during various stages of disuse muscle atrophy have been investigated utilizing a rat hind limb suspension (HS) model. Two distinct components of eEF2k/eEF2 pathway misregulation were demonstrated, observing a significant (P < 0.01) increase in eEF2k mRNA expression as early as 1-day HS and in eEF2k protein level after 3-day HS. We set out to determine whether eEF2k activation is a Ca2+-dependent process with involvement of Cav1.1. The ratio of T56-phosphorylated/total eEF2 was robustly elevated after 3-day HS, which was completely reversed by BAPTA-AM and decreased by 1.7-fold (P < 0.05) by nifedipine. Transfection of C2C12 with pCMV-eEF2k and administration with small molecules were used to modulate eEF2k and eEF2 activity. More important, pharmacologic enhancement of eEF2 phosphorylation induced phosphorylated ribosomal protein S6 kinase (T389) up-regulation and restoration of global protein synthesis in the HS rats. Taken together, the eEF2k/eEF2 pathway is up-regulated during disuse muscle atrophy involving calcium-dependent activation of eEF2k partly via Cav1.1. The study provides evidence, in vitro and in vivo, of the eEF2k/eEF2 pathway impact on ribosomal protein S6 kinase activity as well as protein expression of key atrophy biomarkers, muscle atrophy F-box/atrogin-1 and muscle RING finger-1.

      Graphical abstract

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Pathology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Fanzani A.
        • Conraads V.M.
        • Penna F.
        • Martinet W.
        Molecular and cellular mechanisms of skeletal muscle atrophy: an update.
        J Cachexia Sarcopenia Muscle. 2012; 3: 163-179
        • Gao Y.
        • Arfat Y.
        • Wang H.
        • Goswami N.
        Muscle atrophy induced by mechanical unloading: mechanisms and potential countermeasures.
        Front Physiol. 2018; 9: 235
        • Phillips S.M.
        • Glover E.I.
        • Rennie M.J.
        Alterations of protein turnover underlying disuse atrophy in human skeletal muscle.
        J Appl Physiol (1985). 2009; 107: 645-654
        • Baldwin K.M.
        • Haddad F.
        • Pandorf C.E.
        • Roy R.R.
        • Edgerton V.R.
        Alterations in muscle mass and contractile phenotype in response to unloading models: role of transcriptional/pretranslational mechanisms.
        Front Physiol. 2013; 4: 284
        • Gollnick P.D.
        • Piehl K.
        • Saltin B.
        Selective glycogen depletion pattern in human muscle fibres after exercise of varying intensity and at varying pedalling rates.
        J Physiol. 1974; 241: 45-57
        • Edgerton V.R.
        • Roy R.R.
        Neuromuscular adaptations to actual and simulated spaceflight.
        in: Fregly M.J. Blatteis C.M. Handbook of Physiology. Sect 4: Environmental Physiology. Oxford University Press, New York, NY1996: 721-763
        • Mirzoev T.
        • Tyganov S.
        • Vilchinskaya N.
        • Lomonosova Y.
        • Shenkman B.
        Key markers of mTORC1-dependent and mTORC1-independent signaling pathways regulating protein synthesis in rat soleus muscle during early stages of hindlimb unloading.
        Cell Physiol Biochem. 2016; 39: 1011-1020
        • Stitt T.N.
        • Drujan D.
        • Clarke B.A.
        • Panaro F.
        • Timofeyva Y.
        • Kline W.O.
        • Gonzalez M.
        • Yancopoulos G.D.
        • Glass D.J.
        The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.
        Mol Cell. 2004; 14: 395-403
        • Rhoads R.E.
        Signal transduction pathways that regulate eukaryotic protein synthesis.
        J Biol Chem. 1999; 274: 30337-30340
        • Yoon M.S.
        mTOR as a key regulator in maintaining skeletal muscle mass.
        Front Physiol. 2017; 8: 788
        • Ogasawara R.
        • Fujita S.
        • Hornberger T.A.
        • Kitaoka Y.
        • Makanae Y.
        • Nakazato K.
        • Naokata I.
        The role of mTOR signalling in the regulation of skeletal muscle mass in a rodent model of resistance exercise.
        Sci Rep. 2016; 6: 31142
        • Cannavino J.
        • Brocca L.
        • Sandri M.
        • Bottinelli R.
        • Pellegrino M.A.
        PGC1-alpha over-expression prevents metabolic alterations and soleus muscle atrophy in hindlimb unloaded mice.
        J Physiol. 2014; 592: 4575-4589
        • Hornberger T.A.
        • Hunter R.B.
        • Kandarian S.C.
        • Esser K.A.
        Regulation of translation factors during hindlimb unloading and denervation of skeletal muscle in rats.
        Am J Physiol Cell Physiol. 2001; 281: 179-187
        • Wilson G.J.
        • Moulton C.J.
        • Garlick P.J.
        • Anthony T.G.
        • Layman D.K.
        Post-meal responses of elongation factor 2 (eEF2) and adenosine monophosphate-activated protein kinase (AMPK) to leucine and carbohydrate supplements for regulating protein synthesis duration and energy homeostasis in rat skeletal muscle.
        Nutrients. 2012; 4: 1723-1739
        • Rose A.J.
        • Alsted T.J.
        • Jensen T.E.
        • Kobbero J.B.
        • Maarbjerg S.J.
        • Jensen J.
        • Richter E.A.
        A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions.
        J Physiol. 2009; 587: 1547-1563
        • Browne G.J.
        • Proud C.G.
        Regulation of peptide-chain elongation in mammalian cells.
        Eur J Biochem. 2002; 269: 5360-5368
        • Ryazanov A.G.
        • Davydova E.K.
        Mechanism of elongation factor 2 (EF-2) inactivation upon phosphorylation: phosphorylated EF-2 is unable to catalyze translocation.
        FEBS Lett. 1989; 251: 187-190
        • Pigott C.R.
        • Mikolajek H.
        • Moore C.E.
        • Finn S.J.
        • Phippen C.W.
        • Werner J.M.
        • Proud C.G.
        Insights into the regulation of eukaryotic elongation factor 2 kinase and the interplay between its domains.
        Biochem J. 2012; 442: 105-118
        • Mitsui K.
        • Brady M.
        • Palfrey H.C.
        • Nairn A.C.
        Purification and characterization of calmodulin-dependent protein kinase III from rabbit reticulocytes and rat pancreas.
        J Biol Chem. 1993; 268: 13422-13433
        • Wang X.
        • Li W.
        • Williams M.
        • Terada N.
        • Alessi D.R.
        • Proud C.G.
        Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.
        EMBO J. 2001; 20: 4370-4379
        • Shenkman B.S.
        • Nemirovskaya T.L.
        Calcium-dependent signaling mechanisms and soleus fiber remodeling under gravitational unloading.
        J Muscle Res Cell Motil. 2008; 29: 221-230
        • Hofmann F.
        • Flockerzi V.
        • Kahl S.
        • Wegener J.W.
        L-type CaV1.2 calcium channels: from in vitro findings to in vivo function.
        Physiol Rev. 2014; 94: 303-326
        • Bodine S.C.
        • Latres E.
        • Baumhueter S.
        • Lai V.K.
        • Nunez L.
        • Clarke B.A.
        • Poueymirou W.T.
        • Panaro F.J.
        • Na E.
        • Dharmarajan K.
        • Pan Z.Q.
        • Valenzuela D.M.
        • DeChiara T.M.
        • Stitt T.N.
        • Yancopoulos G.D.
        • Glass D.J.
        Identification of ubiquitin ligases required for skeletal muscle atrophy.
        Science. 2001; 294: 1704-1708
        • Tischler M.E.
        • Rosenberg S.
        • Satarug S.
        • Henriksen E.J.
        • Kirby C.R.
        • Tome M.
        • Chase P.
        Different mechanisms of increased proteolysis in atrophy induced by denervation or unweighting of rat soleus muscle.
        Metabolism. 1990; 39: 756-763
        • Doig J.
        • Griffiths L.A.
        • Peberdy D.
        • Dharmasaroja P.
        • Vera M.
        • Davies F.J.
        • Newbery H.J.
        • Brownstein D.
        • Abbott C.M.
        In vivo characterization of the role of tissue-specific translation elongation factor 1A2 in protein synthesis reveals insights into muscle atrophy.
        FEBS J. 2013; 280: 6528-6540
        • Schakman O.
        • Kalista S.
        • Barbe C.
        • Loumaye A.
        • Thissen J.P.
        Glucocorticoid-induced skeletal muscle atrophy.
        Int J Biochem Cell Biol. 2013; 45: 2163-2172
        • Morey-Holton E.R.
        • Globus R.K.
        Hindlimb unloading rodent model: technical aspects.
        J Appl Physiol (1985). 2002; 92: 1367-1377
        • Xu Q.
        • Yu L.
        • Liu L.
        • Cheung C.F.
        • Li X.
        • Yee S.P.
        • Yang X.J.
        • Wu Z.
        p38 Mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression.
        Mol Biol Cell. 2002; 13: 1940-1952
        • Murphy R.J.
        • Beliveau L.
        • Gardiner P.F.
        • Calderone A.
        Nifedipine does not impede clenbuterol-stimulated muscle hypertrophy.
        Proc Soc Exp Biol Med. 1999; 221: 184-187
        • Goodman C.A.
        • Hornberger T.A.
        Measuring protein synthesis with SUnSET: a valid alternative to traditional techniques?.
        Exerc Sport Sci Rev. 2013; 41: 107-115
        • Pfaffl M.W.
        A new mathematical model for relative quantification in real-time RT-PCR.
        Nucleic Acids Res. 2001; 29: e45
        • Altaeva E.G.
        • Lysenko L.A.
        • Kantserova N.P.
        • Nemova N.N.
        • Shenkman B.S.
        The basal calcium level in fibers of the rat soleus muscle under gravitational unloading: the mechanisms of its increase and the role in calpain activation.
        Dokl Biol Sci. 2010; 433: 241-243
        • Enns D.L.
        • Raastad T.
        • Ugelstad I.
        • Belcastro A.N.
        Calpain/calpastatin activities and substrate depletion patterns during hindlimb unweighting and reweighting in skeletal muscle.
        Eur J Appl Physiol. 2007; 100: 445-455
        • Chen Z.
        • Gopalakrishnan S.M.
        • Bui M.H.
        • Soni N.B.
        • Warrior U.
        • Johnson E.F.
        • Donnelly J.B.
        • Glaser K.B.
        1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor.
        J Biol Chem. 2011; 286: 43951-43958
        • Shahbazian D.
        • Roux P.P.
        • Mieulet V.
        • Cohen M.S.
        • Raught B.
        • Taunton J.
        • Hershey J.W.
        • Blenis J.
        • Pende M.
        • Sonenberg N.
        The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.
        EMBO J. 2006; 25: 2781-2791
        • Lecker S.H.
        • Solomon V.
        • Mitch W.E.
        • Goldberg A.L.
        Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states.
        J Nutr. 1999; 129: 227S-237S
        • Massaccesi L.
        • Goi G.
        • Tringali C.
        • Barassi A.
        • Venerando B.
        • Papini N.
        Dexamethasone-induced skeletal muscle atrophy increases O-GlcNAcylation in C2C12 Cells.
        J Cell Biochem. 2016; 117: 1833-1842
        • Marzuca-Nassr G.N.
        • Vitzel K.F.
        • Murata G.M.
        • Marquez J.L.
        • Curi R.
        Experimental model of hindlimb suspension-induced skeletal muscle atrophy in rodents.
        Methods Mol Biol. 2019; 1916: 167-176
        • Ohira Y.
        • Jiang B.
        • Roy R.R.
        • Oganov V.
        • Ilyina-Kakueva E.
        • Marini J.F.
        • Edgerton V.R.
        Rat soleus muscle fiber responses to 14 days of spaceflight and hindlimb suspension.
        J Appl Physiol (1985). 1992; 73: 51S-57S
        • Redpath N.T.
        • Proud C.G.
        Purification and phosphorylation of elongation factor-2 kinase from rabbit reticulocytes.
        Eur J Biochem. 1993; 212: 511-520
        • Heise C.
        • Gardoni F.
        • Culotta L.
        • di Luca M.
        • Verpelli C.
        • Sala C.
        Elongation factor-2 phosphorylation in dendrites and the regulation of dendritic mRNA translation in neurons.
        Front Cell Neurosci. 2014; 8: 35
        • Sun Y.
        • Caputo C.
        • Edman K.A.
        Effects of BAPTA on force and Ca2+ transient during isometric contraction of frog muscle fibers.
        Am J Physiol. 1998; 275: C375-C381
        • Ito N.
        • Ruegg U.T.
        • Kudo A.
        • Miyagoe-Suzuki Y.
        • Takeda S.
        Activation of calcium signaling through Trpv1 by nNOS and peroxynitrite as a key trigger of skeletal muscle hypertrophy.
        Nat Med. 2013; 19: 101-106
        • Agrawal A.
        • Suryakumar G.
        • Rathor R.
        Role of defective Ca(2+) signaling in skeletal muscle weakness: pharmacological implications.
        J Cell Commun Signal. 2018; 12: 645-659
        • Nemirovskaya T.L.
        • Sharlo K.A.
        Roles of ATP and SERCA in the regulation of calcium turnover in unloaded skeletal muscles: current view and future directions.
        Int J Mol Sci. 2022; 23: 6937
        • Pyr Dit Ruys S.
        • Wang X.
        • Smith E.M.
        • Herinckx G.
        • Hussain N.
        • Rider M.H.
        • Vertommen D.
        • Proud C.G.
        Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase.
        Biochem J. 2012; 442: 681-692
        • Csibi A.
        • Cornille K.
        • Leibovitch M.P.
        • Poupon A.
        • Tintignac L.A.
        • Sanchez A.M.
        • Leibovitch S.A.
        The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse.
        PLoS One. 2010; 5: e8994
        • Otsuka Y.
        • Egawa K.
        • Kanzaki N.
        • Izumo T.
        • Rogi T.
        • Shibata H.
        Quercetin glycosides prevent dexamethasone-induced muscle atrophy in mice.
        Biochem Biophys Rep. 2019; 18: 100618
        • Yeon M.
        • Choi H.
        • Jun H.S.
        Preventive effects of schisandrin A, a bioactive component of Schisandra chinensis, on dexamethasone-induced muscle atrophy.
        Nutrients. 2020; 12: 1255
        • Eo H.
        • Reed C.H.
        • Valentine R.J.
        Imoxin prevents dexamethasone-induced promotion of muscle-specific E3 ubiquitin ligases and stimulates anabolic signaling in C2C12 myotubes.
        Biomed Pharmacother. 2020; 128: 110238